This inventor holds 5 USPTO granted patents. Top assignee: 3M Innovative Properties Company. Active years: 1994-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Arcadia, MN (US) (2001)
- Woodbury, MN (US) (1994 - 2006)
Company Filing History:
Years Active: 1994-2006
Title: Innovator Chan U Ko: Pioneering Transdermal Drug Delivery Solutions
Introduction
Chan U Ko, a dedicated inventor based in Woodbury, Minnesota, has made significant contributions to the field of drug delivery systems. With a portfolio of five patents, her work focuses on advancing transdermal drug delivery technologies, which have the potential to enhance patient care and treatment efficacy.
Latest Patents
One of Chan U Ko's latest patents is for a "Matrix for Transdermal Drug Delivery." This innovative transdermal drug delivery device utilizes a macromonomer-containing acrylate or methacrylate copolymer, combined with a softener and a drug, to facilitate effective drug administration through the skin. Additionally, she has developed a pressure-sensitive skin adhesive that involves a similar copolymer and softener to enhance the adhesion characteristics of transdermal applications. Another notable patent is for an "Adhesive Microsphere Drug Delivery Composition." This composition includes pressure-sensitive adhesive microspheres that incorporate a softening agent and/or a drug, emphasizing the versatility and effectiveness of her invention.
Career Highlights
Throughout her career, Chan U Ko has worked with prominent companies, including the Minnesota Mining and Manufacturing Company (3M). Her contributions within these organizations have propelled advancements in transdermal delivery systems, making her a valuable asset in the research and development of innovative healthcare solutions.
Collaborations
Chan U Ko has collaborated with esteemed colleagues, such as Steven C. Hackett and James E. Garbe. Together, they have explored the challenges and opportunities within transdermal drug delivery, leading to groundbreaking patents that now serve as a foundation for future innovations in the industry.
Conclusion
Chan U Ko's commitment to innovation in transdermal drug delivery showcases her dedication to improving healthcare outcomes. With her impressive repertoire of patents and collaborations with industry leaders, she continues to be a driving force in the realm of medical technology and drug administration solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile